Investment Research & Advisory Group’s Idexx Laboratories IDXX Stock Holding History

Investment Research & Advisory Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.3K	Hold	27	–	–	﹤0.01%	214
2026 Q1	$17.4K	Hold	27	–	–	0.01%	185
2025 Q4	$19.6K	Hold	27	–	–	0.01%	169
2025 Q3	$18.5K	Hold	27	–	–	0.01%	155
2025 Q2	$14.5K	Hold	27	–	–	0.01%	158
2025 Q1	$11.3K	Hold	27	–	–	﹤0.01%	162
2024 Q4	$11.2K	Hold	27	–	–	﹤0.01%	155
2024 Q3	$13.6K	Hold	27	–	–	0.01%	144
2024 Q2	$13.2K	Hold	27	–	–	0.01%	142
2024 Q1	$14.6K	Hold	27	–	–	0.01%	143
2023 Q4	$15K	Hold	27	–	–	0.01%	132
2023 Q3	$11.8K	Hold	27	–	–	0.01%	138
2023 Q2	$13.6K	Hold	27	–	–	0.01%	145
2023 Q1	$13.5K	Hold	27	–	–	0.01%	130
2022 Q4	$11K	Hold	27	–	–	0.01%	132
2022 Q3	$9K	Hold	27	–	–	0.01%	131
2022 Q2	$9K	Buy	+27	New	+$11K	0.01%	140

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Investment Research & Advisory Group's IDXX Position: Q2 2026 in Review

Investment Research & Advisory Group held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 27 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #214.

Investment Research & Advisory Group first reported a position in IDXX in Q2 2022 and has held it in 17 quarters since. The position peaked at $19.6K in Q4 2025. 724 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Investment Research & Advisory Group held 27 shares of Idexx Laboratories worth $15.3K as of Q2 2026.
Investment Research & Advisory Group left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up ﹤0.01% of Investment Research & Advisory Group's portfolio in Q2 2026, its #214 holding.
Investment Research & Advisory Group first reported a position in Idexx Laboratories in Q2 2022 and has held it in 17 quarters since.
Investment Research & Advisory Group's Idexx Laboratories position peaked at $19.6K in Q4 2025.
724 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Investment Research & Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.